Search - tctmd.com

Displaying 221 - 237 of 237

Sort: Relevancy | Date

News Daily News

What Are Hospitals Doing With PCI Appropriateness Reports? Some Say, Not Much

Shelley Wood

November 18, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

News Daily News

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

L.A. McKeown

January 12, 2015

News Daily News

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

L.A. McKeown

January 12, 2015

News Daily News

Análisis de Gastos del ASCERT: CABG Más Caro que PCI pero con Mejores Resultados

L.A. McKeown

January 12, 2015

News Daily News

Meta-analysis: Operator Volume Affects Clinical Outcomes After PCI

L.A. McKeown

June 24, 2014

News Daily News

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Caitlin E. Cox

August 30, 2013

News Daily News

Meta-analysis: No Difference in Complications for Same-Day vs. Next-Day PCI Discharge

L.A. McKeown

April 26, 2013

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Daily News

Selective Use of DES Saves Millions of Dollars a Year

Jason Kahn

August 15, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Daily News

DES Add Over $1.5 Billion in Medicare Costs to Health Care System

Jason Kahn

April 28, 2011

News Daily News

COURAGE: PCI Not Cost-Effective Even for Highly Symptomatic Patients

February 15, 2011

Advertisement

What Are Hospitals Doing With PCI Appropriateness Reports? Some Say, Not Much

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

Análisis de Gastos del ASCERT: CABG Más Caro que PCI pero con Mejores Resultados

Meta-analysis: Operator Volume Affects Clinical Outcomes After PCI

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Meta-analysis: No Difference in Complications for Same-Day vs. Next-Day PCI Discharge

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

PRISM Individualized Informed Consent Improves PCI Choice, Experience

Selective Use of DES Saves Millions of Dollars a Year

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

DES Add Over $1.5 Billion in Medicare Costs to Health Care System

COURAGE: PCI Not Cost-Effective Even for Highly Symptomatic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content